CD34 and infection: Larger cohorts will be needed to more robustly investigate associations between CD34+ cell dynamics, infection, and prematurity-related morbidities, as well as to evaluate the impact of interventions and clinical factors such as blood transfusion, timing of cord clamping, and sampling frequency.